1,200
Participants
Start Date
May 6, 2025
Primary Completion Date
May 1, 2029
Study Completion Date
July 31, 2029
Metronidazole 500 mg
Multi-dose oral MTZ (500 mg twice daily for 7 days) for the treatment of T. vaginalis infection in women and men
Secnidazole 2000 MG
Single-dose 2 g oral SEC for the treatment of T. vaginalis infection in women and men
RECRUITING
University of Alabama at Birmingham [UAB] Gynecology Clinics, Birmingham
NOT_YET_RECRUITING
Segal Trials Healthcare Clinical Data, Inc. 1065 NE 125th St. Suite 417 North Miami, FL 33161, North Miami
RECRUITING
UAB Sexual Health Research Clinic [SHRC], Birmingham
RECRUITING
LSU-CrescentCare Sexual Health Center, New Orleans
University of Alabama at Birmingham
OTHER
Louisiana State University Health Sciences Center in New Orleans
OTHER
Segal Trials Healthcare Clinical Data, Inc
UNKNOWN
Tulane University
OTHER